Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Debra Richardson
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
142 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Gynecologic Oncology Group of Arizona
Phoenix, Arizona, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Gynecologic Oncology Associates-Newport Beach
Newport Beach, California, United States
- University of Connecticut
Farmington, Connecticut, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- Women'S Cancer Associates
St. Petersburg, Florida, United States
- Northeast Georgia Medical Center-Gainesville
Gainesville, Georgia, United States
- Central Georgia Gynecologic Oncology
Macon, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Mcfarland Clinic Pc - Ames
Ames, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Iowa-Wide Oncology Research Coalition Ncorp
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Cancer Center of Kansas - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas - Fort Scott
Fort Scott, Kansas, United States
- Cancer Center of Kansas-Independence
Independence, Kansas, United States
- Cancer Center of Kansas-Kingman
Kingman, Kansas, United States
- Cancer Center of Kansas-Liberal
Liberal, Kansas, United States
- Cancer Center of Kansas - Newton
Newton, Kansas, United States
- Cancer Center of Kansas - Parsons
Parsons, Kansas, United States
- Cancer Center of Kansas - Pratt
Pratt, Kansas, United States
- Cancer Center of Kansas - Salina
Salina, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Dec 2011
- Primary completion
- 27 Jan 2018
- Completion
- 27 Jan 2018
- Last update posted
- 23 Jul 2019
- Registered enrollment
- 106
- Registry id
- NCT01468909
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.